Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Bleeding control after single-ray amputation: Hemocoll vs Avitene vs bone wax

Official title: A Multicentre, Prospective, Randomized, Controlled, Three-Arm Superiority Trial Comparing Hemocoll® FTC, Avitene™ MCH, and Conventional Bone Wax for Cancellous Bone Bleeding Following Single-Ray Amputation

Run by Adichunchanagiri Institute of Medical Sciences, B G Nagara · NCT07788846 · Data updated 2026-11-12

This trial tests whether Hemocoll, Avitene, or bone wax better stop bleeding from exposed bone after a planned single-ray amputation in adults.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment135 (estimated)
SponsorAdichunchanagiri Institute of Medical Sciences, B G Nagara
Academic / other
Locations3 sites (Kolār, Karnataka and 2 other locations)
StatusRecruiting
StartedSeptember 5, 2026
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedOctober 27, 2026
Trial IDNCT07788846 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing planned single-ray amputation with exposed cancellous bone and active bleeding after tourniquet release.

Probably not a fit

Patients with bleeding conditions, hypersensitivity to study materials, or undergoing procedures where cancellous bone bleeding cannot be assessed may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, prospective randomized trial compares three topical hemostatic options for controlling cancellous bone bleeding after tourniquet release in adults undergoing planned single-ray amputation. Participants are randomized 1:1:1 to Hemocoll fibrillar Type-I collagen, Avitene microfibrillar collagen hemostat, or conventional bone wax, with a standardized compression protocol applied to the treated surface. The primary endpoint is complete hemostasis within a time frame specific to the affected bone (phalanx, metacarpal, or metatarsal). Secondary comparisons include Hemocoll versus bone wax and Avitene versus bone wax. The study aims to enroll 135 participants across three tertiary centers in Karnataka, India.

Why it matters

Potential benefit: If successful, patients may experience more reliable bleeding control after amputation, potentially reducing recovery time and complications.

How similar studies have gone: Previous work with topical hemostats suggests potential benefits in bone bleeding, but direct head-to-head data in this exact setting are limited, making this study relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Planned surgical single-ray amputation involving one or more phalangeal, metacarpal or metatarsal bone segments.
* Presence of an exposed cancellous bone surface following planned bone transection.
* Ability to undergo the standardized operative protocol.
* Ability to provide written informed consent.
* Willingness to comply with postoperative follow-up

Exclusion Criteria:

* Known congenital or acquired bleeding disorder.
* Severe uncorrected coagulopathy.
* Severe thrombocytopenia considered clinically significant by the treating team.
* Active major haemorrhage unrelated to the operative field.
* Requirement for major vascular reconstruction during the procedure.
* Procedures in which standardized assessment of cancellous bone bleeding is impossible.
* Known hypersensitivity to bovine or ovine collagen or to bone wax.
* Previous severe adverse reaction to the study haemostatic materials.
* Simultaneous multiple unrelated amputation procedures where attribution of bleeding cannot be standardized.
* Inability to obtain informed consent.
* Any condition considered by the investigator to make participation unsafe or to compromise the integrity of the trial.

Where it's running

  • Sri Devaraj Urs Medical College
    Kolār, Karnataka, India
    Recruiting
  • Adichunchanagiri Institute of Medical Sciences
    Mandya, Karnataka, India
    Recruiting
  • Mysore Medical College and Research Institute
    Mysuru, Karnataka, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.